WallStreetZenWallStreetZen

NASDAQ: NVCT
Nuvectis Pharma Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Nuvectis Pharma revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NVCT annual revenue was $0.0, with N/A growth year-over-year.

NVCT revenue history

Current Revenue
$0.0
Current Earnings
-$19.0M
Current Profit Margin
0%

Be the first to know when NVCT announces revenue.

NVCT Revenue History By Year

NVCT Yearly RevenueNVCT RevenueNVCT ChangeNVCT Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A

1 of 1

Nuvectis Pharma Revenue FAQ

What was NVCT's revenue last quarter?

Nuvectis Pharma (NASDAQ: NVCT) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Nuvectis Pharma's revenue was $0.00.

What was Nuvectis Pharma's revenue in 2024?

Nuvectis Pharma's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Nuvectis Pharma make in a day?

Based on Nuvectis Pharma annual revenue for the past four years, NVCT makes an average of $0.00 per day.

What was Nuvectis Pharma's annual revenue growth in the past year?

As of Q2 2025, Nuvectis Pharma's revenue has grown null year over year. Nuvectis Pharma's revenue in the past year totaled $0.00.

How much does Nuvectis Pharma make in a year?

Nuvectis Pharma's revenue by year for the past four years is:
  • Nuvectis Pharma's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Nuvectis Pharma's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Nuvectis Pharma's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Nuvectis Pharma's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.